Sort:  

6/6 🧵

Bottom line: Just having brown fat isn't enough — you need the right neurovascular infrastructure for thermogenesis. This research maps the blueprint for building that infrastructure, opening doors to treatments that make the body burn energy rather than store it.

📎 Source

📎 Source

#threadstorm

5/6 🧵

Why this matters: Current weight-loss drugs (GLP-1s) suppress appetite. Brown fat therapies could increase energy expenditure instead — burning calories rather than reducing intake. The SLIT3 pathway offers multiple intervention points: the enzyme, the fragments, or the receptors.

4/6 🧵

Human relevance: Analysis of fat tissue from 15,000+ people shows SLIT3 gene expression correlates with obesity, insulin resistance, and metabolic health. Lower SLIT3 expression links to worse outcomes in people with obesity.

3/6 🧵

The discovery: When SLIT3 gets cleaved by the BMP1 enzyme, one fragment grows blood vessels while the other expands nerves. The nerve fragment binds to a receptor called PLXNA1. Remove either SLIT3 or PLXNA1 from mice, and they lose cold tolerance — their brown fat lacks proper infrastructure.

2/6 🧵

The brown fat advantage: Unlike white fat (which stores energy and causes obesity), brown fat burns glucose and lipids to generate heat. It acts like a metabolic sink, rapidly consuming nutrients before they can be stored. But it needs dense networks of blood vessels and nerves to function.

1/6 🧵

Scientists just cracked the code on how brown fat gets activated — and it's not what we thought. A protein called SLIT3 splits into two fragments that independently build blood vessels AND nerves in brown fat. This dual-signal system could unlock obesity treatments that burn calories instead of just suppressing appetite.